Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Fully Functional Bacterial Cell Thrives with Synthetic Genome

By LabMedica International staff writers
Posted on 09 Jun 2010
In a major proof-of-principle study investigators have demonstrated the ability to insert a fully functional artificial genome into a bacterial cell.

To accomplish this task investigators at the J. More...
Craig Venter Institute (San Diego, CA, and Rockville, MD, USA) synthesized the 1.08 million base pair (bp) chromosome of a modified Mycoplasma mycoides genome. To prepare the accurate, digitized M. mycoides genome, the investigators designed 1,078 specific cassettes of DNA that were 1,080 base pairs long. These cassettes were designed so that the ends of each DNA cassette overlapped each of its neighbors by 80 bp. The cassettes were made by the DNA synthesis company, Blue Heron Biotechnology (Bothell, WA, USA).

A three-stage process using a previously described yeast assembly system was employed to build the genome using the 1,078 cassettes. The first stage involved taking 10 cassettes of DNA at a time to build 110 10,000-bp segments. In the second stage, these 10,000-bp segments are taken 10 at a time to produce 11 100,000-bp segments. In the final step, all 11 of the 100-kb segments were assembled into the complete synthetic genome in yeast cells and grown as a yeast artificial chromosome.

The complete synthetic M. mycoides genome was then isolated from the yeast cells and transplanted into Mycoplasma capricolum recipient cells that lacked restriction enzyme genes. The synthetic genome DNA was transcribed into messenger RNA, which in turn was translated into new proteins. The M. capricolum genome either was destroyed by M. mycoides restriction enzymes or was lost during cell replication. After two days viable M. mycoides cells, which contained only synthetic DNA, were clearly visible on Petri dishes containing bacterial growth medium.

Details of the project were published in the May 20, 2010, online edition of the journal Science. Here, the investigators assigned the name Mycoplasma mycoides JCVI-syn1.0 to the synthetic cell. They termed it the proof-of-principle that genomes can be designed in the computer, chemically made in the laboratory, and transplanted into a recipient cell to produce a new self-replicating cell controlled only by the synthetic genome.

Contributing author Dr. Clyde A. Hutchison, a senior researcher at the J. Craig Venter Institute, said, "To me the most remarkable thing about our synthetic cell is that its genome was designed in the computer and brought to life through chemical synthesis, without using any pieces of natural DNA. This involved developing many new and useful methods along the way.”

Related Links:

J. Craig Venter Institute
Blue Heron Biotechnology



New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Human Estradiol Assay
Human Estradiol CLIA Kit
New
Specimen Radiography System
TrueView 200 Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: An innovative deep learning model can accurately predict MSI tumor and immune checkpoint inhibitor responsiveness (Photo courtesy of Jae-Ho Cheong/Yonsei University College of Medicine)

AI Model Accurately Predicts MSI Tumor and Immune Checkpoint Inhibitor Responsiveness

One in three people is expected to develop cancer in their lifetime, and a key factor in patient prognosis is the tumor’s microsatellite status—whether it is stable or shows microsatellite instability-high (MSI-H).... Read more

Industry

view channel
Image: The acquisition of Exosome Diagnostics adds the ExoDx Prostate test to Mdxhealth’s portfolio (Photo courtesy of Bio-Techne)

Bio-Techne Divests Exosome Diagnostics to Reposition Product Portfolio

Bio-Techne Corporation (Minneapolis, MN, USA) has entered into an agreement with Mdxhealth SA (Irvine, CA, USA), which will acquire its Exosome Diagnostics Inc. (Waltham, MA, US) business, including the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.